Burkholderia pseudomallei: Another emerging pathogen in cystic fibrosis

Thorax

Volumn 58, Issue 12, 2003, Pages 1087-1091

  O'Carroll, M R ^a   Kidd, T J ^a   Coulter, C ^a   Smith, H V ^b   Rose, B R ^c   Harbour, C ^c   Bell, S C ^a,d  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b QLD Health Scientific Services   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFTAZIDIME; CHLORAMPHENICOL DERIVATIVE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DNA; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; TETRACYCLINE DERIVATIVE; TIMENTIN; TOBRAMYCIN;

ADOLESCENT; ADULT; ARTICLE; ASIA; AUSTRALIA; BACTERIAL PNEUMONIA; BURKHOLDERIA PSEUDOMALLEI; CASE REPORT; CLINICAL FEATURE; CYSTIC FIBROSIS; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; RESPIRATORY FAILURE; SEPSIS; THAILAND;

ADOLESCENT; ADULT; BURKHOLDERIA PSEUDOMALLEI; COMMUNICABLE DISEASES, EMERGING; CYSTIC FIBROSIS; DNA, BACTERIAL; DRUG RESISTANCE; FEMALE; GENOTYPE; HUMANS; MALE; MELIOIDOSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0348110370     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.12.1087     Document Type: Article

References (25)

1. Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 2000;31:981-6.
2. Visca P, Cazzola G, Petrucca A, et al. Travel-associated Burkholderia pseudomallei infection (melioidosis) in a patient with cystic fibrosis: a case report. Clin Infect Dis 2001;32:e15-6.
3. Schulin T, Steinmetz I. Chronic melioidosis in a patient with cystic fibrosis. J Clin Microbiol 2001;39:1676-7.
4. Dance DAB, Smith MD, Aucken HM, et al. Imported melioidosis in England and Wales. Lancet 1999;353:208.
5. Holland DJ, Wesley A, Drinkovic, et al. Cystic fibrosis and Burkholderia pseudomallei infection: an emerging problem? Clin Infect Dis 2002;35:e138-40.
6. National Committee for Clinical Laboratory Standards. Performance standard for antimicrobial susceptibility testing Document M100-S10. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
7. Aaron SD, Ferris W, Henry DA, et al. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkolderia cepacia. Am J Respir Crit Care Med 2000;161:1206-12.
8. Alexander AD, Huxsoll DL, Warner AR Jr, et al. Serological diagnosis of human melioidosis with indirect hemagglutination and complement fixation tests. Appl Microbiol 1970;20:825-33.
9. Ashdown LR. Indirect haemagglutination test for melioidosis. Med J Aust 1987;147:364-5.
10. - Burkholderia pseudomallei isolates and development of a multiplex PCR procedure for rapid discrimination between the two biotypes. J Clin Microbiol 1999;37:1906-12.
11. Smith MD, Angus BJ, Wuthiekanun V, et al. Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei. Infect Immunol 1997;65:4319-21.
12. Trakulsomboon S, Vuddhakul V, Tharavichitkul P, et al. Epidemiology of arabinose assimilation in Burkholderia pseudomallei isolated from patients and soil in Thailand. Southeast Asian J Trop Med Public Health 1999;30:756-9.
13. Mahenthiralingam E, Bischof J, Byrne SK, et al. DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000;38:3165-73.
14. Segonds C, Heulin T, Marty N, et al. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates. J Clin Microbiol 1999;37:2201-8.
15. Corney B, Colley J, Djordjevic S, et al. Rapid identification of some Leptospira isolates from cattle by random amplified polymorphic DNA fingerprinting. J Clin Microbiol 1993;31:2927-32.
16. Currie BJ, Mayo M, Anstey NM, et al. A cluster of melioidosis cases from an endemic region is clonal and is linked to the water supply using molecular typing of Burkholderia pseudomallei isolates. Am J Trop Med Hyg 2001;65:177-9.
17. Römling U, Tümmler B. Achieving 100% typability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. J Clin Microbiol 2000;38:464-5.
18. Scott IA, Bell AM, Staines DR. Fatal human melioidosis in south-eastern Queensland. Med J Aust 1997;166:197-9.
19. Samuel M, Ti TY. Interventions for treating melioidosis (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Publications, 2002.
20. Lowe P, Engler C, Norton R. Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei. J Clin Microbiol 2002;40:4625-7.
21. Abbink FC, Orendi JM, De Beaufort AJ. Mother-to-child transmission of Burkholderia pseudomallei. N Engl J Med 2001;344:1171.
22. Kunakorn M, Jayanetra P, Tanphaichitra D, Man-to-man transmission of melioidosis. Lancet 1991;337:1290-1.
23. McCormick JB, Sexton DJ, McMurray JG, et al. Human-to-human transmission of Pseudomonas pseudomallei. Ann Intern Med 1975;83:512-3.
24. Webb AK. Flying and cystic fibrosis: getting there and back safely. Thorax 2001;56:821-2.
25. Schwarzmaier A, Riezinger-Geppert F, Schober G, et al. Fulminant septic melioidosis after a vacation in Thailand. Wien Klin Wochenschr 2000;112:892-5.